Enzon Pharmaceuticals Inc
SWB:EZ1
Enzon Pharmaceuticals Inc
SWB:EZ1
Price:
0.0005
EUR
Market Cap:
€37.1k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Enzon Pharmaceuticals Inc
SWB:EZ1
|
US |
|
B
|
Black Sea Property AS
OSE:BSP
|
NO |
|
E
|
Eugene Investment & Securities Co Ltd
KRX:001200
|
KR |
|
T
|
Taihan Textile Co Ltd
KRX:001070
|
KR |
|
Z
|
Zhejiang Bangjie Holding Group Co Ltd
SZSE:002634
|
CN |
|
D&G Technology Holding Co Ltd
HKEX:1301
|
CN |
|
M
|
Maywood Acquisition Corp
NASDAQ:MAYA
|
US |
|
Isofol Medical AB (publ)
STO:ISOFOL
|
SE |
|
V
|
Voyant International Corp
OTC:VOYT
|
US |
|
Brother Industries Ltd
OTC:BRTHF
|
JP |
|
Z
|
Zhejiang Changhua Auto Parts Co Ltd
SSE:605018
|
CN |
|
Gentera SAB de CV
OTC:CMPRF
|
MX |
Multiples-Based Value
The
Multiples-Based Value for
Enzon Pharmaceuticals Inc (EZ1)
under the Base Case is
hidden
EUR.
Compared with the current market price of 0.0005 EUR, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
EZ1 Multiples-Based Value
LOCKED
Multiples Across Competitors
EZ1 Competitors Multiples
Enzon Pharmaceuticals Inc Competitors
Enzon Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Enzon Pharmaceuticals Inc
SWB:EZ1
|
4.5m EUR | 0 | -80.5 | 7.2 | 7.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
374.1B USD | 6.1 | 89.4 | 14.8 | 20.5 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
175.7B USD | 6 | 20.7 | 12.9 | 15.9 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD | 9.4 | 28.5 | 21.4 | 22.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD | 5.7 | 18.2 | 13.7 | 15.6 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR | 11.7 | 37.5 | 40.5 | 41.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD | 3 | 33.2 | 11.2 | 14 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
